Dexcom partners with Eli Lilly surrounding its ongoing diabetes management

By Catherine Sturman
Becoming the first company to introduce the first biosynthetic ‘human’ insulin with recombinant DNA technology in the 1980s, Eli Lilly continues to...

Becoming the first company to introduce the first biosynthetic ‘human’ insulin with recombinant DNA technology in the 1980s, Eli Lilly continues to be a leader in diabetes management.

The company has recently partnered with Dexcom to strengthen its position within the diabetes market. Dexcom will link its smart insulin delivery devices, such as its continuous glucose monitoring (CGM) with Lilly’s Connected Diabetes Ecosystem to strengthen both companies position and fight off growing competition in this space.

Through the Connected Diabetes Ecosystem, both parties will aim to provide a comprehensive solution. Devices such as CGM, smart-pens and insulin pumps, drugs, apps and other analytical tools will be aimed at improving outcomes. Clinical trials are expected to begin by the end of 2017.

Related stories

“Lilly’s Connected Diabetes Ecosystem promises to drive a significant step forward in diabetes management. As technology converges in our industry, we believe that connected systems will become the standard of care over time,” explained Kevin Sayer, President and CEO of Dexcom.

“By combining devices, drugs and technology, we can deliver solutions that adapt to each person’s unique needs in managing their diabetes while also providing compelling advancements for both physicians and payers.”

“The Connected Diabetes Ecosystem relies not only on Lilly’s core diabetes expertise, but also the strength of our key partners such as Dexcom,” commented Enrique Conterno, President of Lilly Diabetes and Lilly USA.

“Dexcom will be an important collaborator in our mission to improve outcomes and reduce the daily burden for people with diabetes.”

 

 

Share

Featured Articles

Tata Consultancy Report Shows AI in Healthcare on Rise

Tata Consultancy Services AI for Business Global Study shows that three-quarters of healthcare leaders are deploying AI to drive innovation and efficiency

McKinsey: Consumers Demand Data-driven Wellness Products

New McKinsey Future of Wellness survey shows that consumers demand data-driven wellness solutions to improve health, sleep, nutrition, fitness & longevity

SpaceX Starlink Launch Boost for Indonesia Healthcare

As SpaceX CEO Elon Musk helps launch new satellite in Indonesia, we look at how the Starlink programme is improving healthcare provision in remote areas

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Sustainability

Walgreens to Sell Over-the-Counter Opioid Overdose Drug

Medical Devices & Pharma

McKinsey Health Institute: Focus on Health Insights Body

Digital Healthcare